when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

MYCOPHENOLATE MOFETIL — FDA approval

April 10, 2026MYCOPHENOLATE MOFETILupdated 5mo ago

community read0 votes

Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

approvalMYCOPHENOLATE MOFETIL — FDA approvalMar 18, 2026 · 200d ago
approvalMYCOPHENOLATE MOFETIL — FDA approvalFeb 23, 2026 · 223d ago
approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 263d ago
approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 263d ago
approvalMYCOPHENOLATE MOFETIL — FDA approvalSep 26, 2024 · 738d ago
approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 782d ago
approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 782d ago
approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 782d ago

same company · ±60 days · 6

approvalGABAPENTIN: GABAPENTIN — FDA approvalApr 2, 2026
recallSTRIDES PHARMA INC recall (Cls II)Mar 25, 2026
approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalMar 23, 2026
approvaldoxycycline ER: DOXYCYCLINE — FDA approvalMar 20, 2026
approvalCABERGOLINE: CABERGOLINE — FDA approvalMar 18, 2026
approvaldoxycycline ER: DOXYCYCLINE — FDA approvalMar 11, 2026

🐶 often sniffed alongside

top 4

tagApproval34 co-mentions · 17 sources
tagSmall Molecule17 co-mentions · 17 sources
companyAurobindo Pharma Ltd8 co-mentions · 8 sources
companyStrides Pharma Inc4 co-mentions · 4 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?